SCHEMBL15460412

SCHEMBL15460412

COc1ccc(/C=C/C(=O)c2cc(C)c(C)c(OC)c2)cc1O

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TUBB1 Q9H4B7 5/20 0.74
TUBB4A P04350 2/20 0.74
TUBB P07437 2/20 0.74
TUBA3C P0DPH7 2/20 0.74
TUBA1B P68363 2/20 0.74
TUBA4A P68366 2/20 0.74
TUBB4B P68371 2/20 0.74
TUBB3 Q13509 2/20 0.74
TUBB2A Q13885 2/20 0.74
TUBB8 Q3ZCM7 2/20 0.74
TUBA3E Q6PEY2 2/20 0.74
TUBA1A Q71U36 2/20 0.74
TUBA1C Q9BQE3 2/20 0.74
TUBB6 Q9BUF5 2/20 0.74
TUBB2B Q9BVA1 2/20 0.74
CALM1 P0DP23 1/20 0.66
ALDH1A1 P00352 2/20 0.61
HPGD P15428 2/20 0.61
LMNA P02545 1/20 0.61
CYP1A1 P04798 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2329685 0.85 TUBB1 (1.00) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL2329679 0.85 TUBB1 (1.00) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL30504103 0.85 TUBB1 (1.00) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL25196076 0.85 TUBB1 (0.79) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL30384079 0.85 TUBB1 (0.79) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL15460399 0.84 ABCG2 (0.55) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL25196870 0.83 CXCL12 (0.80) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL3195246 0.83 CALM1 (0.88) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL25230917 0.83 CXCL12 (0.80) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL31233041 0.83 CXCL12 (0.80) TUBB1TUBB4ATUBBTUBA3CTUBA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9102638-B2 Amidobenzothiazoles and process for the preparation thereof COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-08-11 US disclosed
US-8921552-B2 Benzothiazole hybrids useful as anticancer agents and process for the preparation thereof COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2014-12-30 US disclosed
US-20140039190-A1 BENZOTHIAZOLE HYBRIDS USEFUL AS ANTICANCER AGENTS AND PROCESS FOR THE PREPARATION THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2014-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140039190-A1 BENZOTHIAZOLE HYBRIDS USEFUL AS ANTICANCER AGENTS AND PROCESS FOR THE PREPARATION THEREOF TP53, MCL1, SDHA TUBB1 105/4885TUBB4A 40/4885TUBB 112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.